Our share price analysis, data and how-to-buy guides cover significant market movements in the most popular UK shares in the FTSE 100, US stocks in the DJIA, commodities, indices, and currency pairs. They are designed to help you make more informed decisions about what to invest in, what to trade, and when to execute currency transactions.
Are loss-making fintech investment providers worth the risk?
Robo Advisor Nutmeg reported annual results to the end of December 2019 yesterday and they didn’t make pretty reading, as the business lost £22.0 million over the course of last year, despite a rise in both client numbers and business turnover. That means that Nutmeg burned through £420,000 per week last year, the 2019 losses
Will market volatility rise in September?
Should we expect a potential rise in market volatility in autumn? History suggests yes. Meanwhile, numerous UK large-caps are battered into multi-month lows. Key Events: US Unemployment Rate ECB Meeting next week Viewpoint Autumn has always proved to be a turbulent period for CFD traders and the markets. Many crashes flared up in September and
Best and worst shares of 2019 that could be due a reversal
We are well and truly into the New Year now and whilst markets remain relatively sedate, we have an opportunity to look back and take stock of 2019, to discover what last year may be able to tell us about our portfolio selections for the year ahead. The idea of having a postmortem of 2019’s
UK Equities: Five Sector Themes to Watch in 2020
New year, new investment trends. Here are five potential money-making sector themes to watch for in 2020. 1. Are UK housebuilders overheating? One of the best sector performers over the past decade was undoubtedly housebuilders. Shareholders of Berkeley (BKG), Barratt (read our Barratt Developments (LON:BDEV) share price analysis), Taylor Wimpey (T… To read this article, please
What to watch out for when investing in 2020. Seven key questions asked and answered for trading 2020.
1. Will the world economy slip into a recession? This is the big question. No doubt the global economy is slowing. Regional growth statistics from the EU, parts of Asia and most Latin America economies are coming in below expectations. Reports from many sectors are, too, unexpectedly soft, e.g., car industry. That’s why many central banks
How to Invest in Pharma/Biotech in late-cycle bull markets
Want to invest in Pharma/Biotech companies? Here’s our quick guide on how to Invest in Pharma/Biotech in late-cycle bull markets Health, some say, is a human’s greatest asset. That’s why restoring an ill body back to a healthy state is such a big business. Just recently, Novartis, a Swiss pharmaceutical giant, established a world record